Metraipolis › archive › dc_bd31ad83a618
Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma — Europe PMC PMID:42902345
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42902345
- DOI
- 10.1186/s40164-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T21:53:54.007Z
- SHA-256 of the archived text
910ba40ea7c643603c8aabdf82c1cd7d5091b0747736bccbfd17a4687ae4e3db- Stable URL of this page
https://metraipolis.com/documento/dc_bd31ad83a618
How to cite
Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma — Europe PMC PMID:42902345 — Europe PMC (en), https://europepmc.org/article/MED/42902345 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd31ad83a618 (Metraipolis archive dc_bd31ad83a618, sha256 910ba40ea7c643603c8aabdf82c1cd7d5091b0747736bccbfd17a4687ae4e3db)
BibTeX
@misc{dcbd31ad83a618,
title = {Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma — Europe PMC PMID:42902345},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42902345},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd31ad83a618; sha256 910ba40ea7c643603c8aabdf82c1cd7d5091b0747736bccbfd17a4687ae4e3db},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42902345. Agents can read the archived copy with the MCP tool read_document.